BANK OF AMERICA CORP /DE/
BankPosition in AUPH — Aurinia Pharmaceuticals Inc.
CIK 70858
CHARLOTTE, NC
Position in AUPH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,819,640
-$1,690,153 QoQ
Shares Held
225,082
-39.5% QoQ
Ownership
0.169%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 279 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AUPH Over Time
Shares Held
Position Value (USD)
Derivatives in AUPH
reported options exposure · as of Dec 31, 2021CallValue
$160,090
CallShares
7,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. AUPH ranks #153 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in AUPH
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,819,640 | 225,082 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $5,509,793 | 371,781 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $5,863,792 | 367,636 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,761,060 | 521,363 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $3,987,599 | 470,791 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,193,253 | 397,171 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $574,494 | 63,975 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,280,476 | 174,690 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $870,055 | 152,374 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $583,187 | 116,405 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $624,031 | 69,414 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $654,100 | 84,183 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $613,226 | 63,350 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,132,220 | 103,305 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,765,695 | 408,726 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,949,310 | 259,217 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,277,695 | 127,134 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $680,552 | 54,972 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $160,090 | 7,000 | Call | Defined | 2022-02-08 | |
| 2021-12-31 | $1,422,558 | 62,202 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $972,502 | 43,945 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $746,003 | 57,562 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $923,025 | 71,084 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,412,568 | 102,138 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $416,858 | 28,300 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $319,848 | 19,683 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $305,130 | 21,029 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||